About The Position

The Portfolio Strategy, Analytics, & Enablement Lead for Cardiometabolic Research (CMR) will shape and implement CMR’s long-term vision and lead initiatives that foster growth, innovation, and operational excellence. Working closely with the CMR Lead Team, the role owns the portfolio fact base, assesses portfolio health, frames and leads priority strategic projects, and supports improvements to communications, culture, and capabilities across CMR. The position also helps communicate CMR portfolio status and progress across the broader organization, including to senior leadership. The role leads portfolio-level strategy projects from defining the question through analysis, synthesis, and recommendations to the Core Leadership Team. It develops an integrated view of the CMR portfolio across therapeutic pillars, development stage, modality, target novelty, risk-reward profile, and resource load, using that view to assess portfolio health and recommend improvements. The role partners with therapeutic area leaders to keep program strategies and learning plans current, identifies cross-portfolio issues, supports long-range planning, and owns metrics and dashboards that track strategic objectives. It also monitors competitive, scientific, and regulatory developments relevant to cardiometabolic research. For organizational enablement, the role supports communications such as monthly updates to senior leadership and CMR-wide town halls, and leads program and change management for CMR-wide capability initiatives. It also manages recurring organizational processes and campaigns, including the President's Award proposal process.

Requirements

  • Bachelor's degree in a life science, quantitative, or business field.
  • At least 6 years of experience in pharmaceutical or biotechnology R&D in roles involving portfolio strategy, portfolio management, decision analytics, or strategy consulting serving those functions.
  • Experience leading cross-functional strategy projects from framing through to a leadership decision.

Nice To Haves

  • An advanced degree (PhD, PharmD, MS, or MBA).
  • Working knowledge of drug discovery and early development in cardiometabolic disease, including diabetes, obesity, cardiovascular disease, and their complications.
  • Hands-on experience with portfolio analytics, including risk-adjusted valuation, probability of technical success, and resource and scenario modeling; ability to partner with scientists on quantitative work while owning strategic framing.
  • A track record of designing metrics and dashboards that senior leaders rely on.
  • Ability to draw out diverse opinions in a matrixed organization and synthesize them into recommendations leadership will act on.
  • Clear written and spoken communication for scientific and non-scientific audiences, including governance committees.
  • Self-motivation, scientific curiosity, an enterprise mentality, and a strong grasp of business concepts.

Responsibilities

  • Lead CMR portfolio strategy projects from framing the question through analysis, synthesis, and recommendations to the Core Leadership Team; assemble working teams, drive discussions, and deliver actionable outputs.
  • Develop and maintain an integrated view of the CMR portfolio across therapeutic pillars, development stage, therapeutic modality, target novelty, risk-reward profile, and resource load.
  • Assess portfolio health, characterize risk-reward distribution, project the portfolio’s expected shape as new pillars mature, and recommend improvements.
  • Partner with therapeutic area leaders to keep program strategies and learning plans current and surface cross-portfolio issues, including shared scientific risks, resourcing conflicts, and unexplored white space.
  • Translate CMR strategic priorities into plans, metrics, and dashboards for the long-range planning cycle.
  • Own metrics and dashboards tracking progress against CMR strategic objectives and establish them as a shared reference point in leadership discussions.
  • Track competitive, scientific, and regulatory developments relevant to cardiometabolic research and incorporate their implications into portfolio and planning discussions.
  • Support CMR organizational communications, including monthly updates to senior leadership and CMR-wide town halls in conjunction with therapeutic area leads.
  • Drive program management and change management for CMR-wide capability initiatives, including the Strategic Thinking program.
  • Manage recurring organizational processes and campaigns, including the President's Award proposal process.
  • Support communication of CMR portfolio status and progress across the broader organization, including to senior leadership.

Benefits

  • Company bonus, depending in part on company and individual performance.
  • Eligibility to participate in a company-sponsored 401(k).
  • Pension.
  • Vacation benefits.
  • Eligibility for medical, dental, vision, and prescription drug benefits.
  • Flexible benefits, such as healthcare and/or dependent day care flexible spending accounts.
  • Life insurance and death benefits.
  • Certain time off and leave of absence benefits.
  • Well-being benefits, including an employee assistance program, fitness benefits, and employee clubs and activities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service